CLINICAL STATUS OF RHEUMATOID-ARTHRITIS PATIENTS 18 MONTHS AFTER TREATMENT WITH CHIMERIC ANTI-CD4 ANTIBODY

被引:0
|
作者
MORELAND, LW [1 ]
PRATT, PW [1 ]
BUCY, RP [1 ]
JACKSON, B [1 ]
FELDMAN, J [1 ]
KOOPMAN, WJ [1 ]
机构
[1] UNIV ALABAMA,BIRMINGHAM,AL 35294
来源
CLINICAL RESEARCH | 1992年 / 40卷 / 04期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A845 / A845
页数:1
相关论文
共 50 条
  • [41] Anti-proliferative effects induced by anti-CD4 human/murine chimeric antibody and murine anti-CD4 monoclonal antibody
    Shen Guanxin
    Zhu Huifen
    Wang Xiaolin
    Zhang Yue
    Zhu Zhigang
    Wang Shuo
    Journal of Tongji Medical University, 1999, 19 (1)
  • [42] THERAPY AND THE 1990S - ADVANCES IN IMMUNOTHERAPY OF RHEUMATOID-ARTHRITIS - CLINICAL AND IMMUNOLOGICAL FINDINGS FOLLOWING TREATMENT WITH ANTI-CD4 ANTIBODIES
    HORNEFF, G
    EMMRICH, F
    BURMESTER, GR
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 : 39 - 47
  • [43] CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY FOR RELAPSING POLYCHONDRITIS
    CHOY, EHS
    CHIKANZA, IC
    KINGSLEY, GH
    PANAYI, GS
    LANCET, 1991, 338 (8764): : 450 - 450
  • [44] Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclonal antibody
    Knox, S
    Hoppe, RT
    Maloney, D
    Gibbs, I
    Fowler, S
    Marquez, C
    Cornbleet, PJ
    Levy, R
    BLOOD, 1996, 87 (03) : 893 - 899
  • [45] CHIMERIC CD7 MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
    KIRKHAM, BW
    THIEN, F
    PELTON, BK
    PITZALIS, C
    AMLOT, P
    DENMAN, AM
    PANAYI, GS
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (09) : 1348 - 1352
  • [46] DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL USING CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY, CM-T412, IN RHEUMATOID-ARTHRITIS PATIENTS RECEIVING CONCOMITANT METHOTREXATE
    MORELAND, LW
    PRATT, PW
    MAYES, MD
    POSTLETHWAITE, A
    WEISMAN, MH
    SCHNITZER, T
    LIGHTFOOT, R
    CALABRESE, L
    ZELINGER, DJ
    WOODY, JN
    KOOPMAN, WJ
    ARTHRITIS AND RHEUMATISM, 1995, 38 (11): : 1581 - 1588
  • [47] THYMIC PROCESSING APPEARS TO CONTRIBUTE TO REPOPULATION OF CD4 LYMPHOCYTES AFTER DEPLETION WITH CHIMERIC CD4 ANTIBODY IN REFRACTORY RHEUMATOID-ARTHRITIS
    PRATT, PW
    BUCY, RP
    MORELAND, LW
    KOOPMAN, WJ
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S105 - S105
  • [48] CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY THERAPY IN CROHNS-DISEASE
    CANVADELCAMBRE, V
    JACQUOT, S
    ROBINET, E
    LEMANN, M
    DROUET, C
    DESSAINT, JP
    RABIAN, C
    MODIGLIANI, R
    REVILLARD, JP
    COLOMBEL, JF
    GASTROENTEROLOGY, 1995, 108 (04) : A791 - A791
  • [49] Clinical Pharmacology of an Anti-CD4 Monoclonal Antibody with Enhanced FcRn Binding Affinity in a Phase I Study for Rheumatoid Arthritis
    Scheerens, Heleen
    Zheng, Yanan
    Davis, John
    Su, Zheng
    Deng, Rong
    Fischer, Sally
    Woods, Cynthia
    Fielder, Paul
    Stefanich, Eric
    CLINICAL IMMUNOLOGY, 2010, 135 : S85 - S85
  • [50] OBSERVATIONS ON THE EFFECT OF CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN PATIENTS WITH MYCOSIS-FUNGOIDES
    KNOX, SJ
    LEVY, R
    HODGKINSON, S
    BELL, R
    BROWN, S
    WOOD, GS
    HOPPE, R
    ABEL, EA
    STEINMAN, L
    BERGER, RG
    GAISER, C
    YOUNG, G
    BINDL, J
    HANHAM, A
    REICHERT, T
    BLOOD, 1991, 77 (01) : 20 - 30